Which of the following statements about central diabetes insipidus is incorrect: A) Primary central diabetes insipidus is characterized by the absence of an apparent lesion on pituitary and hypothalamic MRI; B) It can occur in the context of autoimmunity; C) It can occur following immunotherapy; D) Pituitary hemorrhage can cause secondary central diabetes insipidus; E) Pituitary adenomas are the most common cause?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

The INCORRECT Statement is E: Pituitary Adenomas Are NOT the Most Common Cause of Central Diabetes Insipidus

Statement E is incorrect because pituitary adenomas are not the most common cause of central diabetes insipidus. According to the evidence, the most common causes of CDI are neoplasia (25%), surgery (20%), and head trauma (16%), with craniopharyngiomas and germinomas being the most frequent tumors—not pituitary adenomas 1, 2, 3.

Why Each Other Statement is CORRECT:

Statement A: Primary CDI and Normal MRI (CORRECT)

Primary (idiopathic) central diabetes insipidus is indeed characterized by the absence of apparent lesions on pituitary and hypothalamic MRI. Up to 30% of CDI cases are classified as idiopathic when no structural cause is identified 2, 4. These patients may show only the absence of the normal posterior pituitary bright spot on T1-weighted imaging, without other structural abnormalities.

Statement B: Autoimmune Etiology (CORRECT)

CDI can absolutely occur in the context of autoimmunity. Autoimmune CDI accounts for approximately one-third of apparently idiopathic cases 5. The presence of antibodies to arginine vasopressin-secreting cells (AVPcAb) was found in 32.8% of idiopathic CDI patients, particularly in those:

  • Under 30 years at disease onset
  • With history of other autoimmune diseases
  • With radiological evidence of pituitary stalk thickening 5, 6

Lymphocytic hypophysitis and infundibuloneurohypophysitis are recognized autoimmune inflammatory causes 3, 7.

Statement C: Immunotherapy-Induced CDI (CORRECT)

Central diabetes insipidus can occur following immunotherapy with immune checkpoint inhibitors (ICI). Recent case reports document CDI as an adverse event from both CTLA-4 and PD-1/PD-L1 inhibitors 8, 9. This can occur either:

  • In the context of anterior hypophysitis
  • As selective damage to the posterior pituitary
  • As part of hypothalamitis

The mechanism involves ICI-induced autoimmunity affecting the hypothalamic-pituitary axis 8.

Statement D: Pituitary Hemorrhage as Secondary Cause (CORRECT)

Pituitary hemorrhage (apoplexy) is a well-established cause of secondary central diabetes insipidus 10. Pituitary apoplexy involves hemorrhagic or vascular impairment of the pituitary gland and can result in acute hormonal dysfunction including CDI 10.

The Actual Most Common Causes of CDI:

According to the evidence hierarchy 1, 2:

  1. Neoplastic (25%): Craniopharyngiomas and germinomas are the most common tumors, followed by Langerhans cell histiocytosis, metastases, lymphoma, and leukemia
  2. Post-surgical (20%): Following pituitary or hypothalamic surgery
  3. Traumatic (16%): Head trauma with stalk transection
  4. Idiopathic (30%): No identifiable cause, many with autoimmune basis
  5. Inflammatory/Infiltrative: Sarcoidosis, hypophysitis, granulomatous diseases

Pituitary adenomas are actually listed among the less common causes 3, and when they do cause CDI, it's typically through mass effect or apoplexy rather than being a primary mechanism.

Clinical Pitfall to Avoid:

Do not assume that a sellar mass causing CDI is a pituitary adenoma. The differential diagnosis must include craniopharyngioma, germinoma, Langerhans cell histiocytosis, and metastases—all of which are more commonly associated with CDI than adenomas 10.

Related Questions

Why should other forms of diabetes insipidus be considered despite the many other causes of polyuria?
What is the appropriate workup and initial management for an 18‑year‑old male with chronic polyuria, polydipsia, nausea and daily vomiting that have worsened over the past month?
In a 30-year-old male with polydipsia, polyuria, a positive family history of type 2 diabetes mellitus, elevated hemoglobin A1c, low C-peptide, elevated parathyroid hormone, and hypercalcemia, what is the most likely diagnosis?
How should I manage a 58-year-old male presenting with polyuria, polydipsia, random blood glucose 306 mg/dL, HbA1c 9.8 %, blood pressure 150/90 mmHg, dyslipidemia (total cholesterol 229.8 mg/dL, LDL 129.3 mg/dL, triglycerides 272.4 mg/dL), mildly elevated SGOT, borderline vitamin D, and normal renal function?
In a 2.5-year-old male weighing 13.5 kg with minimal milk intake and normal-appearing urine who presents with polyuria, what is the likely diagnosis and appropriate treatment?
What are the recommended medication options and dosing guidelines for treating ADHD in children aged 6 to 12 years?
Is an 88-year-old man with atrial fibrillation, active hematuria, orthostatic hypotension, and intolerance to beta‑blockers a candidate for aspirin and apixaban (Eliquis)?
When should oral prazosin be started and how often repeated in children with scorpion envenomation?
Why would creatine kinase and potassium be elevated?
Is co-administration of vitamin D and vitamin K safe for the infant through breast milk?
What is the arrector pili muscle?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.